Uluslararası Kongrelerde Sunulan Bildiriler:.
1) Isbir CS, Daly RC, Mullany CJ, Dearani J, Orzsulak TA, McGregor CGA.
Use of the internal mammary artery improves results of the combined aortic valve replacement and coronary artery bypass grafting. AHA 71st Scientific Sessions (Dallas, 8–11 Kas 1998). Circulation, 98(17) Suppl I-474, 1997.
Link: link yok
Özet: AVR+CABG’de IMA kullanımının sonuçlara etkisi (AHA özet).
2) Isbir CS, Doğan R, Demircin M, Paşaoğlu İ.
The effect of Aprotinin in ischemia-reperfusion injury: Role of membrane bound enzymes. 8th International Symposium on Cardiovascular Pharmacotherapy (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):48, 1999.
Link: link yok
Özet: Aprotininin İ/R hasarında membran enzimleri üzerine etkisi.
3) Isbir CS, Doğan R, Tuncer M, Farsak B, Kılınç K, Aydın M, Paşaoğlu İ.
Enalapril maleate in ischemia-reperfusion injury. 8th ISCP (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):49, 1999.
Link: link yok
Özet: Enalaprilin İ/R hasarına etkisi (deneysel).
4) Yılmaz H, Ağaçhan B, Aydın M, Isbir CS, Isbir T.
Association between apolipoprotein E and ACE genotype in CAD. 3rd Frontiers in Interventional Cardiology (Jerusalem, 27 Haz–1 Tem 1999). Int J Cardiovasc Interv 2(2):49, 1999.
Link: link yok
Özet: ApoE ve ACE genotipi ile KAH ilişkisi.
5) Isbir CS, Doğan R, Farsak B, Aydın M, Demircin M.
The effect of Captopril on membrane-bound enzymes in I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999).
Link: link yok
Özet: Kaptopril ve membran enzimleri (İ/R).
6) Isbir CS, Doğan R, Farsak B, Aydın M.
The effect of Lisinopril on myocardial I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999).
Link: link yok
Özet: Lisinoprilin miyokard İ/R etkisi.
7) Aydın M, Öztürk O, Zeybek Ü, Yaylım İ, Ergen A, Ak K, Isbir CS.
The late effect of I/R on oxidant/antioxidant system. Turkish-Italian Joint Meeting on Hypertension & Atherosclerosis (Antalya, 30 Mar–2 Nis 2000).
Link: link yok
Özet: İ/R’nin geç dönem oksidan/antioksidan etkileri.
8) Isbir CS, Akgun S, Yılmaz H, Civelek A, Agachan B, Cobanoglu A.
ACE gene polymorphism and failure of AV femoral shunts for hemodialysis. 2nd International Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001).
Link: link yok
Özet: ACE polimorfizmi ile AV şant başarısızlığı ilişkisi.
9) Akgün S, Civelek A, Isbir CS, Çobanoğlu A.
Femoral arteriovenous PTFE grafts: Last choice for hemodialysis access. 2nd Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001).
Link: link yok
Özet: Femoral AV PTFE greftlerin erişim seçeneği olarak sonuçları.
10) Akgün S, Tekeli A, Civelek A, Isbir CS, Ak K, Cobanoglu A.
Prevention of lung injury by FK506 following hind limb I/R in rats. 50th E.S.C.V.S. Congress (Budapeşte, 20–23 Haz 2001). Cardiovasc Surg 8:51, 2001.
Link: link yok
Özet: FK506 ile akciğer hasarının önlenmesi (rat).
11) Isbir CS, Ak K, Zeybek U, Akgün S, Diren S, Civelek A, Tekeli A, Sav A, Çobanoğlu A.
Ischemic preconditioning and nicotinamide in spinal cord protection. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):114, 2002.
Link: link yok
Özet: Omurilik korumasında isk. preconditioning + nikotinamid (deneysel).
12) Isbir CS, Yildirim T, Akgün S, Civelek A, Arsan S.
CABG in severe LV dysfunction. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):84, 2002.
Link: link yok
Özet: Düşük EF’li hastalarda CABG sonuçları.
13) Arsan S, Isbir S, Erentug V.
Ascending aortic aneurysm repair: replacement or external wrapping. 13th WSCTS (San Diego, 1–5 Kas 2003). J Cardiovasc Surg 5(1):43, 2003.
Link: link yok
Özet: Asendan aort anevrizmasında cerrahi seçenekler.
14) Ak K, Akgün S, Tecimer T, Isbir S, Civelek A, Tekeli A, Atalan N, Arsan S.
Histopathological risk factors for postoperative AF in cardiac surgery. 12th ASCVS (İstanbul, 18–22 Nis 2004).
Link: link yok
Özet: Postop AF için histopatolojik belirteçler.
15) Arsan S, Ak K, Akgün S, Civelek A, Isbir S, Aksoy N, Tekeli A, Yıldırım T.
Reduction aortoplasty + external wrapping for tubular ascending AA with concomitant ops. 12th ASCVS (İstanbul, 18–22 Nis 2004).
Link: link yok
Özet: Orta genişlikte asendan aortta redüksiyon aortoplasti/ dış sarma.
16) Tekeli A, Isbir CS, Civelek A, Akgün S, Ergen A, Kurtkaya O, Sav A, Arsan S.
Prevention of lung injury by Iloprost after hind limb I/R in rats. MACCS XVI (26–29 Eyl 2004). Heart Surgery Forum 7 (Suppl 2), 2005.
Link: The Heart Surgery Forum (2005 Suppl) (journal.hsforum.com)
Özet: İloprosta bağlı akciğer koruması (deneysel).
17) Isbir CS, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik S, Birkan Y, Adademir T, Arsan S.
Acetylsalicylic acid resistance in CABG. Update in Cardiology & Cardiovascular Surgery (Bodrum, 29 Eyl–2 Eki 2005). Heart Surgery Forum 8(Suppl 1), 2005.
Link: The Heart Surgery Forum (2005 Suppl) (journal.hsforum.com)
Özet: CABG’de aspirin direnci (özet).
18) Isbir CS, Tekeli A, Ak K, Ergen A, Yılmaz H, Adademir T, Civelek A, Atalan N, Arsan S.
ACE gene polymorphism and acute renal dysfunction after CABG. 16th WSCTS (Ottawa, 17–20 Ağu 2006).
Link: link yok
Özet: ACE polimorfizmi ve CABG sonrası AKI ilişkisi.
19) Tekeli A, Isbir S, Ak K, Atalan N, Adademir T, Civelek A, Arsan S.
Does EuroSCORE predict major adverse events? 16th WSCTS (Ottawa, 17–20 Ağu 2006).
Link: link yok
Özet: EuroSCORE’un MAE öngörüsü.
20) Tekeli A, Zeybek Ü, Agachan B, Ergen A, Ak K, Isbir S, Arsan S.
IL-6 ve IL-8 polymorphisms after CABG: inflammatory cytokines? 16th WSCTS (Ottawa, 17–20 Ağu 2006).
Link: link yok
Özet: Sitokin polimorfizmleri ve post-CABG inflamasyon.
21) Adademir T, Tekeli A, Ak K, Birkan Y, Atalan N, Civelek A, Isbir CS, Arsan S.
Effect of AKI on early mortality after cardiac surgery. 2nd Update in Cardiology & Cardiovascular Surgery (20–24 Eyl 2006). Heart Surgery Forum 9(1):S9, 2006.
Link: link yok
Özet: AKI ve erken mortalite ilişkisi.
22) Ak K, Adademir T, Gürsu O, Tekeli A, Atalan N, Tetik S, Isbir S, Arsan S.
TEG-based transfusion algorithm reduces blood product use after cardiac surgery. 4th Update in Cardiology & Cardiovascular Surgery (28 Kas–2 Ara 2008). Heart Surgery Forum 11(2):S2, 2008.
Link: The Heart Surgery Forum (2008 Suppl) (journal.hsforum.com)
Özet: TEG algoritmasıyla transfüzyon azalır.
23) Ak K, Adademir T, Isbir S, Gürsu O, Tekeli A, Atalan N, Arsan S.
Impact of preoperative anemia on outcome after CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S52, 2008.
Link: The Heart Surgery Forum (2008 Suppl) (journal.hsforum.com)
Özet: Preop anemi olumsuz sonuçla ilişkili.
24) Ak K, Isbir S, Tekeli A, Adademir T, Gürsu O, Güler A, Arsan S.
Preoperative IABP support in high-risk CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S60, 2008.
Link: The Heart Surgery Forum (2008 Suppl) (journal.hsforum.com)
Özet: Yüksek risk CABG’de IABP deneyimi.
25) Ak K, Tetik Ş, Adademir T, Gürsu Ö, Güler A, Isbir S, Yardımcı T, Arsan S.
Impact of early statin therapy on tPA and TFPI after CABG. 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S21, 2009.
Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde) (journal.hsforum.com)
Özet: Erken statin ile tPA/TFPI değişimi.
26) Arsan S, Ak K, Adademir T, Güler A, Isbir S.
Autologous right PA wall for repair of absent PA (TOF+APV). 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S91, 2009.
Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde) (journal.hsforum.com)
Özet: Otolog PA duvarı ile onarım (olgu).
27) Ergen A, Kahraman TÖ, Tekeli A, Turan AN, Ekşi YE, Adıgüzel M, Isbir S, Isbir T.
Plasma myeloperoxidase in MI. 4th International Congress of Molecular Medicine (İstanbul, 27–30 Haz 2011).
Link: link yok
Özet: MPO düzeyleri ve MI ilişkisi.
28) Kurnaz Ö, Yılmaz AH, Isbir S, Isbir T.
PPAR-γ PRO12ALA ve LOX-1 K167N varyantları ve KAH. 4th ICoMM (İstanbul, 27–30 Haz 2011).
Link: link yok
Özet: Genetik varyantlar ve KAH ilişkisi.
29) Görmüş U, Kahraman TÖ, Isbir S, Tekeli A, Isbir T.
MMP2 gen polimorfizmi ve mRNA düzeyi (yüzeyel varis). 4th ICoMM (İstanbul, 27–30 Haz 2011).
Link: link yok
Özet: MMP2 ve varis ilişkisi.
30) Teker Akadam AB, Yılmaz HA, Arat A, Isbir S, Isbir T.
Combined effects of ApoE and PCSK9 R496W in CHD. 4th ICoMM (İstanbul, 27–30 Haz 2011).
Link: link yok
Özet: ApoE+PCSK9 varyant kombinasyonları ve KAH.
31) Timirci-Kahraman O, Görmüş U, Ergen HA, Tekeli A, Isbir S, Isbir T.
mRNA levels of elastin, fibulin-5, LOXL-1, MMP-2/9 in varicose vein. 22nd IUBMB & 37th FEBS (Sevilla, 4–9 Eyl 2012).
Link: link yok
Özet: Varis olgularında matriks ilişkili gen ekspresyonu.
32) Birkan Y, Isbir S, Ak K, Elçi E, Dericioğlu O, Arsan S.
CD34(+) pluripotent MSC therapy in chronic critical limb ischemia. 14th Asian Society for Vascular Surgery (İstanbul, 26–29 Eki 2013).
Link: link yok
Özet: KÇEKİ’de CD34(+) MSC tedavisi.
33) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S.
Five-year results of EVAR for AAA (single center). 14th ASVS (İstanbul, 26–29 Eki 2013).
Link: link yok
Özet: EVAR 5 yıllık tek merkez deneyimi.
34) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S.
Endovascular graft repair of thoracic aortic pathologies (single center). 14th ASVS (İstanbul, 26–29 Eki 2013).
Link: link yok
Özet: Torasik aort endovasküler greft deneyimi.
35) Öztürk NY, Ak K, Erkek N, Isbir S, Arsan S.
VV-ECMO in pediatric ICU: early experience. 1st International Critical Care & Emergency Medicine Congress (İstanbul, 6–8 Kas 2013).
Link: link yok
Özet: Çocuk yoğun bakımda VV-ECMO deneyimi.
36) Yalındağ NO, Ak K, Besci T, Keleş B, Kolbaş N, Erkek N, Isbir S, Arsan S.
VV-ECLS for infant with ARDS & airleaks (first success). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):293, 2013.
Link: link yok
Özet: ARDS’li infantta VV-ECLS başarı öyküsü (özet).
37) Öztürk NO, Ak K, Yasa U, Barys S, Isbir S, Arsan S, Erkek N, Barlan İ.
VV-ECLS weaning without anticoagulation (IPEX, child). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):294, 2013.
Link: link yok
Özet: Antikoagülansız VV-ECLS ayırma (olgu).
38) Isbir S, Baltacioglu F, Ak K, Kararmaz A, Elçi E, Arsan S.
Hybrid procedures for extensive aortic pathologies (22 hasta). AATS Aortic Symposium (New York, 24–25 Nis 2014).
Link: link yok
Özet: Yaygın aort patolojilerinde hibrit yaklaşım.
39) Birkan Y, Ak K, Dericioğlu O, Isbir S, Arsan S.
CD34(+) MSC therapy in chronic critical limb ischemia. 11th International Congress of Update in Cardiology & Cardiovascular Surgery (26–29 Mar 2015). JACC Suppl S6, 2015.
Link: link yok
Özet: KÇEKİ’de kök hücre tedavisi (kongre özeti).
40) Isbir S.
Hybrid debranching and endovascular repair of extensive TAAA. EuroPCR (Paris, 19–21 May 2015).
Link: EuroPCR 2015 Abstract Book (PDF) (PCR Online)
Özet: TAAA’da hibrit debranching + endovasküler yaklaşım (özet).
41) Isbir S, Birkan Y.
EVH + MECC + Autotransfusion. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015).
Link: link yok
Özet: Minimal invaziv cerrahide EVH-MECC-autotransfüzyon deneyimi.
42) Isbir S.
Hybrid thoracoabdominal aortic aneurysm repair. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015).
Link: link yok
Özet: TAAA’da hibrit onarım deneyimi.
43) Isbir S.
Sutureless valve replacement as a concomitant procedure. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015).
Link: link yok
Özet: Eş zamanlı sütürsüz kapak replasmanı uygulaması.
